Neuralink, the brain-computer interface (BCI) venture founded by Elon Musk, is now working on implants designed to help people with blindness regain vision. During a recent discussion with startup accelerator Y Combinator, Musk shared new insights into Neuralink’s developments, including its next ambitious step: direct stimulation of the visual cortex.
Musk explained that the company is preparing for its first vision-related human implants within the next six to twelve months. The goal is to write directly into the brain’s visual cortex, potentially allowing even those who are completely blind to experience visual input. While not restoring biological eyesight, the chip would simulate vision by stimulating the brain’s visual processing center.
He revealed that one of Neuralink’s test monkeys has had the visual implant for three years already, and although the resolution may be low at first, future versions could reach high-definition levels and even perceive ultraviolet or infrared light — creating experiences beyond human norm.
Neuralink made headlines in 2021 with its “Monkey MindPong” demo, in which a monkey controlled a video game with its thoughts. Since then, the company has secured FDA approval for human trials and aims to use its chip to aid those with paralysis by enabling thought-based control of computers and robotic systems.
The broader BCI field is rapidly growing. Apple has partnered with Synchron and Nvidia to explore thought-based control within its ecosystem. Other companies like Paradromics and Precision Neuroscience are also progressing, with recent milestones such as first human implants and regulatory clearances.
What gives Neuralink a unique edge is its synergy with Musk’s other ventures. Technologies from Tesla, SpaceX, and xAI could integrate with Neuralink’s systems — such as Tesla’s Optimus robot or xAI’s advancements in deep learning — to create a connected ecosystem where users can act with mere thought.
Despite the excitement, safety and precision remain critical. Brain implant procedures are highly complex, and ensuring reliable outcomes is essential for the technology’s long-term success. If done right, this innovation could redefine the future of human-machine interaction and healthcare.
Powered by Markelitics.com
Bullwaves is a brand name and a trading name with multiple entities and authorised in various jurisdictions, such as Equitex Capital Limited (Registration No. 8434948-1), a company authorized and regulated by the Financial Services Authority (the "FSA", licence no. SD185) and Moonance LLC, a company regulated by MISA in Comoros Island.
Bullwaves.global website is owned by Moonance LLC, a company incorporated in St. Vincent & the Grenadines with registration no. 2141 LLC 2022 And registered address at First Floor, First St Vincent Bank Ltd Building, James Street, Kingstown, St. Vincent and the Grenadines.
Moonance LLC is authorized and regulated by MISA with License Number T2022122
ETX Services Limited with company registration number HE455407, a company registered in Cyprus with registered address Archiepiskopou Makariou lll 160, 3026 Limassol is appointed as Independent Representative and Distributor.
ETX Services Ltd is not the Licensed Entity in the EU but only acts as the Service entity for Equitex Capital Ltd.
Risk Disclaimer:
Over-the-counter derivatives are complex instruments and come with a high risk of losing your initial capital rapidly due to leverage. You should consider whether you understand how over-the-counter derivatives work and whether you can afford to take the high level of risk to your capital. Investing in over-the-counter derivatives carries significant risks and is not suitable for all investors.
When acquiring our derivative products you have no entitlement, right or obligation to the underlying financial asset. Moonance LLC is not a financial advisor and all services are provided on an execution only basis. Information is of a general nature only and does not consider your financial objectives, needs or personal circumstances. Important legal documents in relation to our products and services are available on our website. You should read and understand these documents before applying for any Bullwaves products or services and obtain independent professional advice as necessary.
Regional Restrictions:
The information or services described on this website is not directed at or offered to residents of Belgium, North Korea, United States, Afghanistan, Belarus, Central African Republic, China, Cuba, Libya, Nicaragua, Palestinian Authority/Gaza/West Bank, Venezuela and to jurisdictions on the FATF and EU/UN sanctions lists or any other person in any jurisdiction where such distribution or use would be contrary to local laws or regulations. For more information please contact our support. Clients who onboarded via www.bullwaves.com can contact our support team at support@bullwaves.com.For complaints please email us at compliance@bullwaves.com